1
|
Lee WM: Hepatitis B virus infection. N
Engl J Med. 337:1733–1745. 1997. View Article : Google Scholar : PubMed/NCBI
|
2
|
Lok AS: Chronic hepatitis B. N Engl J Med.
346:1682–1683. 2002. View Article : Google Scholar : PubMed/NCBI
|
3
|
Bruix J, Sherman M, Llovet JM, Beaugrand
M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M
and Rodés J: EASL Panel of Experts on HCC: Clinical management of
hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL
conference. European Association for the Study of the Liver. J
Hepatol. 35:421–430. 2001. View Article : Google Scholar : PubMed/NCBI
|
4
|
Jang JW, Kwon JH, You CR, Kim JD, Woo HY,
Bae SH, Choi JY, Yoon SK and Chung KW: Risk of HBV reactivation
according to viral status and treatment intensity in patients with
hepatocellular carcinoma. Antivir Ther. 16:969–977. 2011.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Kang MK, Kim MS, Kim SK, Ye GW, Lee HJ,
Kim TN and Eun JR: High-dose radiotherapy with intensity-modulated
radiation therapy for advanced hepatocellular carcinoma. Tumori.
97:724–731. 2011.PubMed/NCBI
|
6
|
Yeo W and Johnson PJ: Diagnosis,
prevention and management of hepatitis B virus reactivation during
anticancer therapy. Hepatology. 43:209–220. 2006. View Article : Google Scholar : PubMed/NCBI
|
7
|
Yeo W, Lam KC, Zee B, Chan PS, Mo FK, Ho
WM, Wong WL, Leung TW, Chan AT, Ma B, et al: Hepatitis B
reactivation in patients with hepatocellular carcinoma undergoing
systemic chemotherapy. Ann Oncol. 15:1661–1666. 2004. View Article : Google Scholar : PubMed/NCBI
|
8
|
Francisci D, Falcinelli F, Schiaroli E,
Capponi M, Belfiori B, Flenghi L and Baldelli F: Management of
hepatitis B virus reactivation in patients with hematological
malignancies treated with chemotherapy. Infection. 38:58–61. 2010.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Kohrt HE, Ouyang DL and Keeffe EB:
Systematic review: Lamivudine prophylaxis for chemotherapy-induced
reactivation of chronic hepatitis B virus infection. Aliment
Pharmacol Ther. 24:1003–1016. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Yeo W, Chan PK, Hui P, Ho WM, Lam KC, Kwan
WH, Zhong S and Johnson PJ: Hepatitis B virus reactivation in
breast cancer patients receiving cytotoxic chemotherapy: A
prospective study. J Med Virol. 70:553–561. 2003. View Article : Google Scholar : PubMed/NCBI
|
11
|
Nagamatsu H, Kumashiro R, Itano S,
Matsugaki S and Sata M: Investigation of associating factors in
exacerbation of liver damage after chemotherapy in patients with
HBV-related HCC. Hepatol Res. 26:293–301. 2003. View Article : Google Scholar : PubMed/NCBI
|
12
|
Lalazar G, Rund D and Shouval D:
Screening, prevention and treatment of viral hepatitis B
reactivation in patients with haematological malignancies. Br J
Haematol. 136:699–712. 2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Chou CH, Chen PJ, Jeng YM, Cheng AL, Huang
LR and Cheng JC: Synergistic effect of radiation and interleukin-6
on hepatitis B virus reactivation in liver through stat 3 signaling
pathway. Int J Radiation Oncology Biol Phys. 75:1545–1552. 2009.
View Article : Google Scholar
|
14
|
Huang W, Zhang W, Fan M, Lu Y, Zhang J, Li
H and Li B: Risk factors for hepatitis B virus reactivation after
conformal radiotherapy in patients with hepatocellular carcinoma.
Cancer Sci. 105:697–703. 2014. View Article : Google Scholar : PubMed/NCBI
|